ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CDIO Cardio Diagnostics Holdings Inc

0.75
-0.0015 (-0.20%)
Apr 24 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 117,699
Bid Price 0.7303
Ask Price 0.75
News -
Day High 0.79

Low
0.171

52 Week Range

High
3.56

Day Low 0.730101
Company Name Stock Ticker Symbol Market Type
Cardio Diagnostics Holdings Inc CDIO NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0015 -0.20% 0.75 17:04:36
Open Price Low Price High Price Close Price Prev Close
0.75 0.730101 0.79 0.75 0.7515
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
643 117,699 $ 0.7572772 $ 89,131 - 0.171 - 3.56
Last Trade Time Type Quantity Stock Price Currency
19:58:07 90 $ 0.75 USD

Cardio Diagnostics Holdings Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
15.18M 20.52M - 17k -8.38M -0.41 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Cardio Diagnostics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No CDIO Message Board. Create One! See More Posts on CDIO Message Board See More Message Board Posts

Historical CDIO Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.011.090.7301010.8150657404,663-0.26-25.74%
1 Month1.321.500.7301011.04332,901-0.57-43.18%
3 Months2.132.400.7301011.60489,647-1.38-64.79%
6 Months0.2123.560.1711.367,493,6540.538253.77%
1 Year2.533.560.1711.333,921,848-1.78-70.36%
3 Years4.258.49990.1712.053,317,977-3.50-82.35%
5 Years4.258.49990.1712.053,317,977-3.50-82.35%

Cardio Diagnostics Description

Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenetic EngineTM for cardiovascular disease to become the leading medical technology company for enabling improved prevention, early detection, and assists in the treatment of cardiovascular disease.

Your Recent History

Delayed Upgrade Clock